Publikationen im NUM

Toptana T, Eckermann L, Pfeiffer AE, et al . Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?. J Clin Virol. 2021; 135      [DOI] 

Metzendorf M, Featherstone RM. Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production. Res Synth Methods. 2021 Jun.;      [DOI] 

Hildebrandt J, Metzendorf MI, Jakob T. Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister. GMS Med Inform Biom Epidemiol. 2021; 17(3):Doc12.      [DOI]      [Datei] 

Popp M, Kranke P, Meybohm P, Metzendorf M, Skoetz N, Stegemann MS, Weibel S. Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges. BMJ Evid Based Med. 2021; 2021bmjebm-2021-111791.      [DOI] 

Wachinger J, Schirmer M, Täuber N, et al . Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study. BMJ Paediatr Open. 2021; 5(1):      [DOI]      [Datei] 

Tielker JM, Weber JP, Simon ST, Bausewein C, Stiel S, Schneider N. Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLOS ONE. 2021 Jul.; 16(7):e0254056.      [DOI]      [Datei] 

Tielker JM, Weber JP, Simon ST, Bausewein C, Stiel S, Schneider N. Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLoS ONE. 2021; 16(7):e0254056.      [DOI] 

Muenchhoff M, Graf A, Krebs S, et al . Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Euro Surveill. 2021; 26(43):      [DOI]      [Datei] 

Thun S, Sass J, Bartschke A. German Corona Consensus Datensatz (GECCO): Verbesserter Austausch von COVID-19-Forschungsdaten. kma - Klinik Management aktuell. 2021; 26(06):55—56.      [DOI] 

Gruber A, Firsching T, Trimpert J, Dietert K. Hamster models of COVID-19 pneumonia reviewed: How human can they be?. Vet Pathol. 2021;

Schmidt M, Kugai S, Amarell N, Weltermann B. Handlungsfähigkeit von Hausärzt*innen während der COVID-19-Pandemie. DocV-15-05. 2021;      [DOI] 

Klein JAF, Krüger LJ, Tobian F, et al . Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med Microbiol Immunol. 2021; 210(4):      [DOI]      [Datei] 

Hadzibegovic S, Lena A, Churchill T, Ho J, Potthoff S, Denecke C, Rösnick L, Heim K, Kleinschmidt M, Sander L, others . Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail. 2021; 23(11):1891—1902.      [DOI] 

Groß R, et al . Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants. EBioMedicine. 2021; 75103761.      [DOI] 

Tenbusch M, Schumacher S, Vogel E, et al . Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. Lancet Infect Dis. 2021; 21(9):      [DOI] 

Rössler M, Jacob J, Risch L, Tesch F, Enders D, Wende D, Jucknewitz R, Weidinger O, Batram M, Ballesteros P, Baßler S, Hertle D, Repschläger U, Richter N, Schulte C, Schramm A, Sobik F, Treskova-Schwarzbach M, Scholz S, Walker J, others . Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen. 2021;      [DOI] 

Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke ea. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells. Mucosal Immunol. 2021; 141381—1392.

Lehmann M, Allers K, Heldt C, et al . Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunol. 2021; 1-12.      [DOI] 

Barros-Martins J, Hammerschmidt SI, Cossmann A. Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. MedRxiv. 2021;      [DOI]      [Datei] 

Trump S, Lukassen S, Anker SM, Chua RL, Liebig J, Thurmann ea. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021; 39705—716.      [DOI] 

Walsh C, Tafforeau P, Wagner W, et al . Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods. 2021; 18(12):1532-1541.      [DOI] 

Barros-Martins J, et al . Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nature Medicine. 2021; 271525—1529.      [DOI] 

Burnett DL, et al . Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability. Immunity. 2021; 542908—2921.e6.      [DOI] 

Schrezenmeier E, et al . Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis. Frontiers in immunology. 2021; 12690698.      [DOI] 

Ahrens KF, Neumann RJ, Kollmann B, Brokelmann J, Werthern NM, Malsyhau A, Weichert D, Lutz B, Fiebach CJ, Wessa M, others . Impact of COVID-19 lockdown on mental health in Germany: Longitudinal observation of different mental health trajectories and protective factors. Translational Psychiatry. 2021; 11(1):1—10.      [DOI] 

Mühlemann B, et al . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;      [DOI] 

Mühlemann B, Thibeault C, Hillus D, Helbig E, Lippert L, Tober-Lau P, Schwarz T, Müller M, group P, Witzenrath M, others . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021;      [DOI] 

Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch A, Kasten M, Zapatero-Belinchón F, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand J, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan G, Höfer A, Kühnel M, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer T, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021 Aug.; 16(8):e0255335.      [DOI] 

Dauletbaev N, Kuhn S, Holtz S, Waldmann S, Niekrenz L, Müller BS, Bellinghausen C, Dreher M, Rohde GGU, Vogelmeier C. Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol. BMJ Open. 2021; 11(9):e053819.      [DOI] 

Müller A, Melzow FS, Göstemeyer G, Paris S, Schwendicke F. Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers. International Journal of Environmental Research and Public Health. 2021; 18(11):5710.      [DOI] 

Hennig V, et al . Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia. Orphanet Journal of Rare Diseases. 2021; 16373.      [DOI] 

Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, others . Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;      [DOI] 

Dickel S, Grimm C, Popp M, Struwe C, Sachkova A, Golinski M, Seeber C, Fichtner F, Heise D, Kranke P, Meissner W, Laudi S, Voigt-Radloff S, Meerpohl J, Jabs J, Mutters N, Moerer O, Group On Behalf Of The German CEOsys Study . Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey. GMS Hyg Infect Control. 2021; 16Doc21.      [DOI] 

Köster AM, Bludau A, Devcic SK, Scheithauer S, Mardiko AA, Schaumann R. Infection surveillance measures during the COVID-19 pandemic in Germany. GMS hygiene and infection control. 2021; 16Doc27.      [DOI] 

Köster A, Bludau A, Devcic S, et al . Infection surveillance measures during the COVID-19 pandemic in Germany. GMS Hyg Infect Control. 2021; 16      [DOI] 

Wyler E, Adler JM, Eschke K, Alves GT, Peidli S, Pott ea. Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models. bioRxiv. 2021;      [DOI] 

Houwaart T, Belhaj S, Tawalbeh E, et al . Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community. MedRxiv. 2021;      [DOI] 

Schroeder S, Pott F, Niemeyer D, Veith T, Richter A, Muth ea. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021; 2e210—e218.      [DOI] 

Burns J, Movsisyan A, Stratil J, Biallis R, Coenen M, Emmert-Fees K, Geffert K, Hoffmann S, Horstick O, Laxy M, Klinger C, Kratzer S, Litwin T, Norris S, Pfadenhauer L, Philipsborn P, Sell K, Stadelmaier B, Voss S, Wabnitz K, Rehfuess E. International travel-related control measures to contain the COVID-19 pandemic: a rapid review. Cochrane Database of Systematic Reviews. 2021; 3      [DOI] 

Strobl S, Roth W. Internationale wissenschaftliche Publikationsaktivität zu COVID-19 [International publication activity during the COVID-19 pandemic]. Pathologe. 2021; 42(2):224-230.

Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos L, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews. 2021; 2021(8):CD015061.      [DOI] 

Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos S, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews. 2021; CD015061.      [DOI] 

Halwe S, Kupke A, Vanshylla K, et al . Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection. Viruses. 2021; 13(8):      [DOI]      [Datei] 

Halwe S, et al . Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021; 13      [DOI] 

Bošnjak B, et al . Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents. Frontiers in Immunology. 2021; 12772240.      [DOI] 

Bošnjak B, Odak I, Barros-Martins J, et al . Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents. Front Immunol. 2021; 12      [DOI]      [Datei] 

Popp M, Stegemann M, Metzendorf M, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021CD015017.      [DOI] 

Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S. Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection. 2021;      [DOI] 

Vanshylla K, et al . Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell host & microbe. 2021;      [DOI] 

Schmidt M, Löwe C, Kugai S, Thielmann A, Weltermann B. Kommunikations- und Kooperationsstrukturen von Hausärzt*innen und Gesundheitsämtern – Erkenntnisse der egePan-Studie. DocV-22-02. 2021;      [DOI]